Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward
Majdy Idrees, Ghazwan Butrous, Ana Mocunbi, B.K.S. Sastry, Ahmed S. Ibrahim, Khalid Alobaidallah, Ahmed Hassan, Ayman AH Farghaly, Magdi H. Yacoub
Abstract
Pulmonary hypertension (PH) is a disease that can only be appropriately managed in the ‘rich’ developed countries, as both diagnostic and therapeutic interventions are extremely expensive and expectations for these to be adopted by the developing, economically-challenged countries are neither practical nor realistic. Furthermore, most of the enormous advances in understanding the pathobiology of PH and the subsequent evidence-based diagnostic and complex treatment algorithms came from the developed world.
Topics & Concepts
MedicinePulmonary hypertensionIntensive care medicineDeveloping countryPsychological interventionPulmonary diseaseDiseaseEconomic growthPathologyCardiologyInternal medicineEconomicsPsychiatryPulmonary Hypertension Research and TreatmentsVascular Anomalies and TreatmentsLiver Disease and Transplantation